Results 231 to 240 of about 1,398,780 (286)

Scaling up home‐visiting to promote early childhood development and prevent violence in Rwanda: a hybrid type‐2 effectiveness‐implementation trial

Journal of Child Psychology and Psychiatry, EarlyView.
Background Children in impoverished families–especially those affected by violence–face risks to healthy development. In the years of strong economic recovery since the 1994 Genocide Against the Tutsi, the Rwandan Government has invested in early child development, social and child protection and violence prevention, but few strategies for scaling ...
Candace J. Black, Matias Placencio‐Castro, Gabriela Phend, Jean Marie Vianney Havugimana, Grace Umulisa, Pacifique Uwamahoro, Marie Gaudence Nyirahabimana, Laura Bond, Kayla Hernandez, Sarah KG Jensen, Ursula Kajani, Shauna M. Murray, Laura B. Rawlings, Vincent Sezibera, Theresa S. Betancourt   +14 more
wiley   +1 more source

Attenuation of a Virulent Porcine Deltacoronavirus Strain DHeB1 via Serial Passage in LLC-PK1 Cells. [PDF]

Viruses
Zhang Y, Liu K, Chen L, Yuan M, Lu H, Xiao S, Fang L.   +6 more
europepmc   +1 more source

Development of a qPCR Tool for Detection, Quantification, and Molecular Characterization of Infectious Laryngotracheitis Virus Variants in Chile from 2019 to 2023. [PDF]

Animals (Basel)
Gatica T, Salgado S, Reyes H, Loncoman C.   +3 more
europepmc   +1 more source

Narcolepsy and rapid eye movement sleep

Journal of Sleep Research, Volume 34, Issue 2, April 2025.
Summary Since the first description of narcolepsy at the end of the 19th Century, great progress has been made. The disease is nowadays distinguished as narcolepsy type 1 and type 2. In the 1960s, the discovery of rapid eye movement sleep at sleep onset led to improved understanding of core sleep‐related disease symptoms of the disease (excessive ...
Francesco Biscarini, Lucie Barateau, Fabio Pizza, Giuseppe Plazzi, Yves Dauvilliers   +4 more
wiley   +1 more source

Glycan site loss in two egg-adapted live attenuated influenza vaccine strains does not cause antigenic mismatches. [PDF]

J Gen Virol
Hirst JC, Napier A, Burbidge D, Scott K, Lindo V, Watanabe Y, Dibben O.   +6 more
europepmc   +1 more source

The Sleep Opportunity, Need and Ability (SONA) Theory

Journal of Sleep Research, EarlyView.
ABSTRACT ‘How much sleep does one need?’ is a critical question that has been difficult to answer. The long history of sleep research has culminated in population‐derived normative values of 7 to 9 h of sleep per night to avoid dysfunction. Such a wide range is sufficiently large that one cannot know what is required for any given individual.
Hannah Scott, Michael Perlis
wiley   +1 more source

Intranasal Administration of Cold-Adapted Live-Attenuated Eurasian Avian-like H1N1 Vaccine Candidate Confers Protection Against Different-Lineage H1N1 Viruses in Mice. [PDF]

Vaccines (Basel)
Zhong Q, Song Z, Meng F, Wang Y, Zhang Y, Feng Z, Zhang Y, Zhai Y, Chen Y, Qiao C, Chen H, Yang H.   +11 more
europepmc   +1 more source

Moderate to Severe Obstructive Sleep Apnea Is a Risk Factor for Severe COVID‐19—A Nationwide Cohort Study

Journal of Sleep Research, EarlyView.
ABSTRACT The impact of obstructive sleep apnea (OSA) and positive airway pressure (PAP) treatment on COVID‐19 severity is unclear. In this population‐based, nationwide study using multi‐register data, we aimed to assess if OSA is a risk factor for COVID‐19 severity and how adherence to PAP treatment and clinical characteristics affect the risk. Swedish
Mirjam Ljunggren, Andreas Palm, Magnus Ekström, Josefin Sundh, Ludger Grote, Huiqi Li, Fredrik Nyberg, Össur Ingi Emilsson   +7 more
wiley   +1 more source

PipC affects the virulence of <i>Salmonella enterica</i> serovar <i>Enteritidis</i> and its deletion strain provides effective immune protection in mice. [PDF]

Front Microbiol
Zhang L, Chen Y, Yan Z, Li Y, Yang X, Chen L, Zhang Y, Chen Y, Li Y, Shi Q, Wu T.   +10 more
europepmc   +1 more source

From leprosy to ground zero: Imagining futures in a world of elimination

Medical Anthropology Quarterly, EarlyView.
Abstract Achieving a target of zero—zero disease, zero disability, and zero discrimination—has become the dominant focus of campaigns to control or eliminate diseases, from HIV/AIDS to malaria to leprosy. Given the historical failure of most eradication programs over the last century, such teleological imaginings of disease‐free futures might seem ...
James Staples
wiley   +1 more source